English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Type 2 diabetes mellitus (T2DM) is a metabolic disease defined by hyperglycemia. If not treated, chronic and even short periods (i.e. weeks) of undesirable hyperglycemia increases the risk for developing diabetic microvascular complications such as retinopathy, neuropathy, nephropathy, foot ulcers and amputations, and macrovascular complications such as cardiovascular disease including stroke [1,2]. Achieving a nearnormal glycemic level reduces the risk of microvascular complications [3]. Current guidelines recommend individualized targets of hemoglobin A1c (HbA1c): <48 mmol/mol (6.5%) for younger patients with an early un-complicated T2DM, <53 mmol/mol (7.0%) when the tight control is difficult to achieve, <58 mmol/mol (7.5%) for patients with longer diabetes duration and established complications or a higher risk of hypoglycemia. Lastly, between 58 and 75 mmol/mol (7.5 – 9.0%) for patients who aim to be symptom-free only [4].

diabetes

Identification of Risk Markers for Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study with Focus on Quality Assurance Based on Real World Data